A Highly Tumor‐Permeating DNA Nanoplatform for Efficient Remodeling of Immunosuppressive Tumor Microenvironments

Abstract The immunosuppressive tumor microenvironment and limited intratumoral permeation have largely constrained the outcome of tumor therapy. Herein, we report a tailored DNA structure‐based nanoplatform with striking tumor‐penetrating capability for targeted remodeling of the immunosuppressive tumor microenvironment in vivo. In our design, chemo‐immunomodulator (gemcitabine) can be precisely grafted on DNA sequences through a reactive oxygen species (ROS)‐sensitive linker. After self‐assembly, the gemcitabine‐grafted DNA structure can site‐specifically organize legumain‐activatable melittin pro‐peptide (promelittin) on each vertex for intratumoral delivery and further function as the template to load photosensitizers (methylene blue) for ROS production. The tailored DNA nanoplatform can achieve targeted accumulation, highly improved intratumoral permeation, and efficient immunogenic cell death of tumor cells by laser irradiation. Finally, the immunosuppressive tumor microenvironment can be successfully remodeled by reducing multi‐type immunosuppressive cells and enhancing the infiltration of cytotoxic lymphocytes in the tumor. This rationally developed multifunctional DNA nanoplatform provides a new avenue for the development of tumor therapy.